Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 69
Filtrar
1.
Eur Rev Med Pharmacol Sci ; 26(8): 2794-2801, 2022 04.
Artigo em Inglês | MEDLINE | ID: mdl-35503624

RESUMO

OBJECTIVE: The nitric oxide (NO) metabolite nitrite has been shown to attenuate hyperglycemia via its increase in insulin sensitivity and glucose uptake. However, the oral use of nitrite is limited due to its potential formation of the carcinogenic N-nitrosamines via reaction of acidic nitrite and the secondary amines. We investigated the anti-diabetic effect of sodium nitrite (SN) combined with glutathione (GSH) in streptozotocin (STZ)-induced diabetic mice for potential use of GSH as a protective agent in future nitrite therapy. MATERIALS AND METHODS: STZ-induced diabetic mice were orally treated for 5 weeks with vehicle, SN, GSH or SN + GSH. Oral glucose tolerance test and the measurement of fasting blood glucose (FBG) and glycosylated hemoglobin (HbA1c) levels were carried out to evaluate anti-diabetic effects of SN and SN + GSH. Plasma levels of total NO metabolites (NOx) were measured to confirm nitrite absorption. RESULTS: SN and SN + GSH significantly improved the glucose tolerance (p < 0.05), but GSH alone did not. The efficacy of combination treatment with SN and GSH in improving the glucose tolerance was higher than that of SN alone. Oral treatment with SN or SN + GSH significant reduced FBG and HbA1c levels (p < 0.05). Interestingly, daily oral administration of SN + GSH was more effective in reducing FBG and HbA1c levels than that of SN alone. Administration of SN or SN + GSH significantly increased plasma NOx levels (p < 0.05), and combination treatment with SN + GSH was more effective in increasing plasma NOx levels than that with SN alone. CONCLUSIONS: Combination treatment with SN and GSH is more effective in controlling hyperglycemia and increasing the plasma NOx levels in an experimental mouse model of diabetes. Since oral administration of GSH has been shown to be non-toxic in humans, the combination of SN and GSH may be important in potential future nitrite therapy.


Assuntos
Diabetes Mellitus Experimental , Glutationa , Hiperglicemia , Nitrito de Sódio , Animais , Antioxidantes/administração & dosagem , Antioxidantes/metabolismo , Glicemia/metabolismo , Diabetes Mellitus Experimental/metabolismo , Glucose/metabolismo , Glutationa/administração & dosagem , Hemoglobinas Glicadas/metabolismo , Hiperglicemia/tratamento farmacológico , Camundongos , Óxido Nítrico/metabolismo , Nitrito de Sódio/administração & dosagem , Estreptozocina
2.
J Periodontal Res ; 45(2): 177-83, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20470258

RESUMO

BACKGROUND AND OBJECTIVE: Although heme oxygenase-1 (HO-1) plays a key role in inflammation, its anti-inflammatory effects and mechanism of action in periodontitis are still unknown. This study aimed to identify the effects of HO-1 on the proinflammatory mediators activated by nicotine and lipopolysaccharide (LPS) stimulation in human periodontal ligament (PDL) cells. MATERIAL AND METHODS: The production of nitric oxide (NO) and prostaglandin E(2) (PGE(2)) was evaluated using Griess reagent and an enzyme immunoassay, respectively. The expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) and HO-1 proteins was evaluated by Western blot analysis. RESULTS: Lipopolysaccharide and nicotine synergistically induced the production of NO and PGE(2) and increased the protein expression of iNOS, COX-2 and HO-1. Treatment with an HO-1 inhibitor and HO-1 small interfering RNAs blocked the LPS- and nicotine-stimulated NO and PGE(2) release as well as the expression of iNOS and COX-2. CONCLUSION: Our data suggest that the nicotine- and LPS-induced inflammatory effects on PDL cells may act through a novel mechanism involving the action of HO-1. Thus, HO-1 may provide a potential therapeutic target for the treatment of periodontal disease associated with smoking and dental plaque.


Assuntos
Ciclo-Oxigenase 2/efeitos dos fármacos , Heme Oxigenase-1/farmacologia , Lipopolissacarídeos/farmacologia , Nicotina/farmacologia , Óxido Nítrico Sintase Tipo II/efeitos dos fármacos , Ligamento Periodontal/efeitos dos fármacos , Androstadienos/farmacologia , Antracenos/farmacologia , Linhagem Celular , Inibidores de Ciclo-Oxigenase 2/farmacologia , Dinoprostona/análise , Dinoprostona/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Heme Oxigenase-1/antagonistas & inibidores , Heme Oxigenase-1/genética , Humanos , Mediadores da Inflamação/análise , Proteínas Quinases JNK Ativadas por Mitógeno/antagonistas & inibidores , Metaloporfirinas/farmacologia , NF-kappa B/efeitos dos fármacos , Óxido Nítrico/análise , Óxido Nítrico/antagonistas & inibidores , Óxido Nítrico Sintase Tipo II/antagonistas & inibidores , Ligamento Periodontal/citologia , Ligamento Periodontal/enzimologia , Inibidores de Fosfoinositídeo-3 Quinase , Protoporfirinas/farmacologia , RNA Interferente Pequeno/genética , RNA Interferente Pequeno/farmacologia , Transfecção , Wortmanina
3.
Eur Rev Med Pharmacol Sci ; 21(4): 890-899, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-28272690

RESUMO

OBJECTIVE: Nephrotoxicity is one of the major side effects that limit the use of cisplatin in cancer therapy. Cisplatin-induced apoptosis in renal cells is associated with reactive oxygen species (ROS)-mediated p53 activation. Licorice (Glycyrrhiza uralensis Fischer) is one of the most widely used medicinal herbs in Korea, China and Japan. The aim of the study was to evaluate the protective effects of licorice extract (LE) and its active compound glycyrrhizic acid (GA) against cisplatin-induced nephrotoxicity in human renal proximal tubular epithelial (HK-2) cells. MATERIALS AND METHODS: HK-2 cells were pretreated with LE or GA for 1 h and then treated with 40 µM of cisplatin for indicated times under the serum-free condition. Cell viability was evaluated by MTT assay. Apoptosis was evaluated by flow cytometric analysis and caspase-3 activity. The intracellular ROS levels were determined by DCFH-DA assay. The expression and phosphorylation levels of protein were evaluated by Western blot and densitometry analysis. RESULTS: When treating HK-2 cells with LE or GA, both of them alleviated cisplatin-induced cytotoxicity and apoptosis. LE and GA inhibited caspase-3 activity and polymerase (PARP) cleavage in cisplatin-treated cells. LE and GA also inhibited p53 expression and its phosphorylation as well as ROS production in cells exposed to cisplatin. Meanwhile, LE and GA enhanced cisplatin-induced p21 expression, which then led to S-phase arrest in cell cycle and limited cell growth. Presumably, increased p21 expression may contribute to cellular prevention from cisplatin-induced apoptosis, because p21 is the key molecule to cytoprotection during cisplatin-induced nephrotoxicity. CONCLUSIONS: These results suggest that LE and GA ameliorate cisplatin-induced apoptosis through reduction of ROS-mediating p53 activation and promotion of p21 expression in HK-2 cells.


Assuntos
Cisplatino/efeitos adversos , Células Epiteliais/efeitos dos fármacos , Ácido Glicirrízico/farmacologia , Extratos Vegetais/farmacologia , Espécies Reativas de Oxigênio/metabolismo , Antineoplásicos/efeitos adversos , Apoptose/efeitos dos fármacos , Linhagem Celular , Inibidor de Quinase Dependente de Ciclina p21/metabolismo , Células Epiteliais/metabolismo , Glycyrrhiza/química , Humanos , Túbulos Renais Proximais/citologia , Proteína Supressora de Tumor p53/metabolismo
4.
J Dent Res ; 85(6): 515-9, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16723647

RESUMO

UNLABELLED: Cyclosporine A (CsA) is a widely used immunosuppressant but with significant side-effects, such as gingival overgrowth. This study investigates how CsA induces gingival proliferation and shows the effects of the CsA-associated signaling messengers, IL-6 and TGF-beta1, on gingival proliferation. CsA increased both IL-6 and TGF-beta1 levels. In addition to CsA, an IL-6 or TGF-beta1 treatment also induced gingival fibroblast proliferation. Inhibiting the cytokine resulted in the suppression of CsA-induced proliferation. MAPKs and PI3K are known to be involved in cell proliferation. Therefore, the effect of CsA on the kinase activities was examined. The results showed that both p38 MAPK and PI3K are essential for gingival fibroblast proliferation. TGF-beta1 and IL-6 and their associated signaling transduction may be novel bona fide molecular targets for the prevention of gingival overgrowth in CsA-treated patients. ( ABBREVIATIONS: MAPK, mitogen-activated protein kinase; P13K, phosphatidylinositol 3-kinase.)


Assuntos
Ciclosporina/farmacologia , Gengiva/efeitos dos fármacos , Crescimento Excessivo da Gengiva/induzido quimicamente , Imunossupressores/farmacologia , Northern Blotting , Contagem de Células , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , MAP Quinases Reguladas por Sinal Extracelular/efeitos dos fármacos , Fibroblastos/efeitos dos fármacos , Gengiva/citologia , Humanos , Immunoblotting , Imunoprecipitação , Interleucina-6/farmacologia , MAP Quinase Quinase 4/efeitos dos fármacos , Fosfatidilinositol 3-Quinases/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos , Fatores de Tempo , Fator de Crescimento Transformador beta/efeitos dos fármacos , Fator de Crescimento Transformador beta/farmacologia , Fator de Crescimento Transformador beta1 , Proteínas Quinases p38 Ativadas por Mitógeno/efeitos dos fármacos
5.
Clin Chim Acta ; 365(1-2): 270-8, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16242122

RESUMO

BACKGROUND: Carbon monoxide (CO) and nitric oxide (NO) each have unique roles for various inflammatory states, including inflammatory bone resorption. Although it is known that NO can induce the expression of the cytoprotective enzyme HO-1, there is no information as to whether the protective effect of CO requires NO production or whether CO must induce the expression of HO-1 to exert its functional effects. METHODS: Murine osteoblast cells, MC3T3E1 osteoblasts, were cultured for CO and NO-associated HO-1 experiments and were transfected with pcDNA 3, pcDNA 3-HO-1, control siRNA or HO-1 siRNA using Nucleofector. For cell death measurement, MTT and annexin V assays were used. We performed Western blotting to check the expressions of HO-1 and iNOs and measured the HO-1 enzyme activity. We also measured the amounts of nitrite and nitrate using Griess reagents. RESULTS: The increased expression of HO-1 is required for the protective effect of NO and a single treatment of CO can increase the expression of HO-1, and this is also important for the protective effect of CO in MC3T3E1 osteoblasts. CO as well as NO attenuates the TNF-alpha-induced apoptosis in osteoblasts. The anti-apoptotic effect of CO or NO is not mediated by cGMP, and CO has no effect on the release of NO. The inhibition of HO-1 with using the HO-1 inhibitor ZnPP or HO-1 siRNA resulted in a striking increase of apoptosis in the CO/TNF-alpha-treated cells. Furthermore, HO-1 overexpression showed resistance against the TNF-alpha-induced cytotoxicity in the MC3T3E1 osteoblasts. CONCLUSIONS: There is a need for HO-1 expression to mediate the protection provided by exogenous CO or NO in osteoblasts.


Assuntos
Apoptose/fisiologia , Monóxido de Carbono/fisiologia , Heme Oxigenase (Desciclizante)/metabolismo , Óxido Nítrico/fisiologia , Osteoblastos/citologia , Fator de Necrose Tumoral alfa/fisiologia , Células 3T3 , Animais , Western Blotting , Camundongos , Osteoblastos/enzimologia
6.
Eur Rev Med Pharmacol Sci ; 19(12): 2303-10, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26166660

RESUMO

OBJECTIVE: Indoxyl sulfate (IS) has been reported to induce endoplasmic reticulum (ER) stress in tubular cells and to inhibit the cell proliferation via ER stress and ERK/IL-6/p21 pathways. This study has investigated the effect of apigenin on IS-induced ER stress in immortalized human renal proximal tubular HK-2 cells. MATERIALS AND METHODS: Human Kidney 2 (HK-2) cells were treated with IS (5 mM) in the absence or presence of apigenin (10 µM) or salubrinal (20 µM) for indicated times under the serum-free condition. Cell viability was evaluated by MTT assay. The levels of protein expression and phosphorylation were evaluated by Western blot analysis. RESULTS: In HK-2 cells, apigenin completely inhibited IS-induced ER stress, as indicated by decreased expression of CHOP, ATF4 and GRP78, although the phosphorylated level of eIF2α did not decrease. IS-induced expression levels of IL-6 and p21 proteins were also inhibited by apigenin, with no significant changes in ERK activation. The suppression of cell proliferation by IS was abolished by salubrinal, an ER stress inhibitor, but not by apigenin. Apigenin inhibited the phosphorylation of Akt and GSK-3ß in IS-treated HK-2 cells. The phosphorylation of GSK-3ß, which was inhibited by apigenin, resulted in hypo-phosphorylation of retinoblastoma (Rb) protein, which was associated with the decrease in cyclin D1 expression. CONCLUSIONS: These results suggest that apigenin may inhibit IS-induced ER stress and expression of IL-6 and p21 proteins in HK-2 cells. It is most likely that apigenin, together with its inhibitory effect on ER stress, may also suppress the cell growth by inducing the loss of Rb phosphorylation, which was associated with the decrease in cyclin D1 expression by GSK-3ß activation through the inhibition of PI3K/Akt pathway.


Assuntos
Apigenina/farmacologia , Inibidor de Quinase Dependente de Ciclina p21/biossíntese , Estresse do Retículo Endoplasmático/fisiologia , Indicã/toxicidade , Interleucina-6/biossíntese , Túbulos Renais Proximais/metabolismo , Fator de Transcrição CHOP/biossíntese , Ciclo Celular/efeitos dos fármacos , Ciclo Celular/fisiologia , Linhagem Celular Transformada , Proliferação de Células/efeitos dos fármacos , Proliferação de Células/fisiologia , Inibidor de Quinase Dependente de Ciclina p21/antagonistas & inibidores , Chaperona BiP do Retículo Endoplasmático , Estresse do Retículo Endoplasmático/efeitos dos fármacos , Humanos , Indicã/antagonistas & inibidores , Interleucina-6/antagonistas & inibidores , Túbulos Renais Proximais/efeitos dos fármacos , Fator de Transcrição CHOP/antagonistas & inibidores
7.
Eur Rev Med Pharmacol Sci ; 19(16): 3125-32, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26367737

RESUMO

OBJECTIVE: Endothelial dysfunction associated with many cardiovascular diseases is largely due to reduced nitric oxide (NO) derived from endothelial NO synthase (eNOS). Piceatannol (trans-3,4,3',5'-tetrahydroxystilbene; Pic) is reported to have cardiovascular therapeutic effects. However, the cellular and molecular mechanisms underlying the cardioprotective effects of Pic are still unclear. Here, we investigated whether Pic could influence endothelial NO release in human umbilical vein endothelial cells (HUVECs). MATERIALS AND METHODS: In HUVECs exposed to Pic, NO production and phosphorylation of eNOS and protein kinase B (Akt) were determined by using a commercially available NO assay kit and Western blot analysis, respectively. RESULTS: Pic stimulated dose- and time-dependent NO production via eNOS phosphorylation. Pic also stimulated dose-dependent phosphorylation of Akt. Interestingly, NO production and eNOS phosphorylation in response to Pic were significantly abolished by the phosphoinositide 3-kinase (PI3K)/Akt inhibitor LY294002. CONCLUSIONS: Pic is capable of inducing eNOS phosphorylation and the subsequent NO release, presumably, by activating PI3K/Akt pathway. The potential efficacy of Pic, a natural hydroxylated analog and a metabolite of resveratrol, may aid in the prevention of cardiovascular diseases characterized by endothelial dysfunction.


Assuntos
Células Endoteliais/efeitos dos fármacos , Óxido Nítrico Sintase Tipo III/metabolismo , Óxido Nítrico/metabolismo , Estilbenos/farmacologia , Células Cultivadas , Células Endoteliais/enzimologia , Células Endoteliais/metabolismo , Humanos , Fosfatidilinositol 3-Quinases/metabolismo , Fosforilação/efeitos dos fármacos
8.
Free Radic Biol Med ; 28(3): 390-6, 2000 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-10699750

RESUMO

The effects of ionizing irradiation on the nitric oxide (NO) production in murine embryonic liver cell line, BNL CL.2 cells, were investigated. Various doses (5-40 Gy) of radiation made BNL CL.2 cells responsive to interferon-gamma alone for the production of NO in a dose-dependent manner. Small amounts of lipopolysaccharide (LPS) or tumor necrosis factor-alpha (TNF-alpha) synergized with IFN-gamma in the production of NO from irradiated BNL CL.2 cells, even though LPS or TNF-alpha alone did not induce NO production from the same cells. Immunoblots showed parallel induction of inducible nitric oxide synthase (iNOS). NO production in irradiated BNL CL.2 cells by IFN-gamma or IFN-gamma plus LPS was decreased by the addition of catalase, suggesting that H(2)O(2) produced by ionizing irradiation primed the cells to trigger NO production in response to IFN-gamma or IFN-gamma plus LPS. Furthermore, the treatment of nongamma-irradiated BNL CL.2 cells with H(2)O(2) made the cells responsive to IFN-gamma or IFN-gamma plus LPS for the production of NO. This study shows that ionizing irradiation has the ability to induce iNOS gene expression in responsive to IFN-gamma via the formation of H(2)O(2) in BNL CL.2 murine embryonic liver cells.


Assuntos
Raios gama , Interferon gama/farmacologia , Lipopolissacarídeos/farmacologia , Óxido Nítrico Sintase/biossíntese , Animais , Linhagem Celular , Embrião de Mamíferos , Indução Enzimática/efeitos dos fármacos , Indução Enzimática/efeitos da radiação , Peróxido de Hidrogênio/metabolismo , Cinética , Fígado , Camundongos , Óxido Nítrico/metabolismo , Proteínas Recombinantes/farmacologia , Salmonella enteritidis , Fator de Necrose Tumoral alfa/farmacologia
9.
Cancer Lett ; 205(1): 23-9, 2004 Mar 08.
Artigo em Inglês | MEDLINE | ID: mdl-15036657

RESUMO

Ginsenosides from Panax ginseng are metabolized by human intestinal bacteria after oral administration of ginseng extract. 20(S)-Protopanaxatriol (PPT) is one of the major metabolites of ginsenosides. Inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) are important enzymes that mediate inflammatory processes. Improper up-regulation of iNOS and/or COX-2 has been associated with the pathogenesis of inflammatory diseases and certain types of human cancers. Here, we investigated whether PPT could modulate iNOS and COX-2 expressions in RAW 264.7 macrophages stimulated with the endotoxin lipopolysaccharide (LPS). We found that PPT blocked the increase in LPS-induced iNOS and COX-2 expressions through inactivation of nuclear factor-kappaB by preventing I-kappaBalpha phosphorylation and degradation. Thus, it may be possible to develop PPT as a useful agent for chemoprevention of cancer or inflammatory diseases.


Assuntos
Isoenzimas/efeitos dos fármacos , Macrófagos/efeitos dos fármacos , NF-kappa B/efeitos dos fármacos , Óxido Nítrico Sintase/efeitos dos fármacos , Prostaglandina-Endoperóxido Sintases/efeitos dos fármacos , Sapogeninas/farmacologia , Triterpenos/farmacologia , Animais , Western Blotting , Células Cultivadas , Ciclo-Oxigenase 2 , Ensaio de Desvio de Mobilidade Eletroforética , Ginsenosídeos/metabolismo , Isoenzimas/biossíntese , Lipopolissacarídeos/farmacologia , Ativação de Macrófagos , Macrófagos/metabolismo , Camundongos , NF-kappa B/metabolismo , Óxido Nítrico Sintase/biossíntese , Óxido Nítrico Sintase Tipo II , Prostaglandina-Endoperóxido Sintases/biossíntese
10.
Cancer Lett ; 159(2): 189-95, 2000 Oct 31.
Artigo em Inglês | MEDLINE | ID: mdl-10996731

RESUMO

The effects of water-soluble chitosan oligomers (WSCO) on the synthesis of nitric oxide (NO) by murine peritoneal macrophages and on macrophage-mediated cytotoxicity towards murine fibrosarcoma Meth A cells were investigated. WSCO alone had no effect on NO synthesis and killing of tumor cells. However, treatment of macrophages with a combination of WSCO and interferon-gamma (IFN-gamma) synergically increased NO synthesis and enhanced killing of tumor cells. The synergism between IFN-gamma and WSCO in NO synthesis and tumoricidal activity was mainly dependent on increased secretion of tumor necrosis factor-alpha by WSCO.


Assuntos
Quitina/análogos & derivados , Quitina/farmacologia , Citotoxicidade Imunológica/efeitos dos fármacos , Interferon gama/farmacologia , Macrófagos Peritoneais/efeitos dos fármacos , Óxido Nítrico/biossíntese , Animais , Anticorpos Monoclonais/farmacologia , Quitosana , Meios de Cultivo Condicionados/farmacologia , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Macrófagos Peritoneais/imunologia , Macrófagos Peritoneais/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Óxido Nítrico Sintase/efeitos dos fármacos , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo II , Solubilidade , Células Tumorais Cultivadas/citologia , Células Tumorais Cultivadas/efeitos dos fármacos , Fator de Necrose Tumoral alfa/imunologia , Fator de Necrose Tumoral alfa/metabolismo
11.
Cancer Lett ; 174(1): 17-24, 2001 Dec 10.
Artigo em Inglês | MEDLINE | ID: mdl-11675148

RESUMO

The root of Paeonia suffruticosa ANDREWS is an important Chinese crude drug used in many traditional prescriptions. 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG), a major component of this crude drug, was found to exhibit in vitro growth-inhibiting effect on human hepatocellular carcinoma cell line, SK-HEP-1 cells. The growth-inhibitory effect was related to the ability of PGG not only to cause a G(0)/G(1) phase arrest but also to suppress the activation of nuclear factor-kappa B. Neither apoptosis nor necrosis was observed in the cells treated with PGG. These findings suggest that PGG could be a candidate for developing a low-toxic anticancer agent.


Assuntos
Antineoplásicos/farmacologia , Carcinoma Hepatocelular/patologia , Taninos Hidrolisáveis , Taninos/farmacologia , Apoptose/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , DNA/metabolismo , Ensaio de Desvio de Mobilidade Eletroforética , Fase G1/efeitos dos fármacos , Humanos , NF-kappa B/metabolismo , Necrose , Fase de Repouso do Ciclo Celular/efeitos dos fármacos , Células Tumorais Cultivadas
12.
Leuk Res ; 25(4): 339-46, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11248331

RESUMO

Water-soluble chitosan oligomer (WSCO) has been reported to have anticancer activity, immuno-enhancing effect and antimicrobial activity. However, other biological activities are unknown. Herein, we have shown that WSCO is able to inhibit proliferation of human leukemia HL-60 cells and induce these cells to differentiate. Treatment with WSCO for 4 days resulted in a concentration-dependent reduction in HL-60 cell growth as measured by cell counting and MTT assay. This effect was accompanied by a marked increase in the proportion of G(0)/G(1) cells as measured by flow cytometry. WSCO also induced differentiation of the cells as measured by phorbol ester-dependent reduction of NBT, morphological changes as examined by Wright-Giemsa staining and expression of CD11b but not of CD14 as analysed by flow cytometry, indicating differentiation of HL-60 cells toward granulocyte-like cells. A combination of low dose of WSCO with all-trans retinoic acid, a differentiating agent toward granulocyte-like cells, exhibited a synergistic effect on the differentiation. In addition, treatment of HL-60 cells with WSCO for 6 or 8 days resulted in the induction of apoptosis as assayed qualitatively by agarose gel electrophoresis and quantitatively by Annexin V technique using flow cytometry. Collectively, there is a potential for WSCO in the treatment of myeloid leukemia.


Assuntos
Diferenciação Celular/efeitos dos fármacos , Quitina/farmacologia , Granulócitos/citologia , Leucemia Promielocítica Aguda/tratamento farmacológico , Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Ciclo Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Quitina/análogos & derivados , Quitosana , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Células HL-60/efeitos dos fármacos , Células HL-60/patologia , Humanos , Leucemia Promielocítica Aguda/patologia , Tretinoína/farmacologia
13.
Mol Cells ; 12(2): 178-84, 2001 Oct 31.
Artigo em Inglês | MEDLINE | ID: mdl-11710518

RESUMO

Experimental autoimmune uveoretinitis (EAU) is a T cell-mediated autoimmune disease of posterior uvea that closely resembles a human disease. The uveitogenic effector T cell has a Th1-like phenotype [high interferon-gamma (IFN-gamma), low interleukin-4 (IL-4)], and genetic susceptibility to EAU that is associated with an elevated Th1 response. Suppression of CD4+ Th1 cells for the treatment of autoimmune disease is an attractive potential therapeutic approach. Nitric oxide (NO) has been implicated in the pathogenesis of several inflammatory and autoimmune diseases. In this study, we investigated the potential role of NO as an immunoregulator to alter Th1/Th2 cytokine production, as well as to inhibit the interphotoreceptor retinoid binding protein (IRBP)-induced EAU, a CD4+ Th1 cell-mediated autoimmune disease. Injection of IRBP (100 microg) into two footpads resulted in severe EAU. The beginning peak of the disease was days 12 to 15 after immunization. Oral treatment with molsidomine (MSDM), a NO donor, began 24 h before IRBP immunization to the end of the experiments, which resulted in a significant inhibition of the disease by clinical and histopathological criteria. When MSDM was administered until day 21, a complete reduction of incidence and severity of EAU was observed. To investigate the cytokine alterations from Th1 to Th2 cytokines by MSDM, the cytokines were assayed in a culture medium of IRBP-stimulated inguinal lymphocytes. IRBP-immunized rats secreted a high concentration of IFN-gamma and a low concentration of IL-10. In contrast, MSDM treatment enhanced IL-10 secretion and tended to decrease IFN-gamma secretion. In conclusion, we show that the administration of NO suppresses EAU by altering the Th1/Th2 balance of inflammatory immune responses. We suggest that NO may be useful in the therapeutic control of autoimmune uveitis.


Assuntos
Doenças Autoimunes/imunologia , Doenças Autoimunes/prevenção & controle , Proteínas do Olho , Doadores de Óxido Nítrico/farmacologia , Óxido Nítrico/imunologia , Retinite/imunologia , Retinite/prevenção & controle , Células Th1/efeitos dos fármacos , Células Th1/imunologia , Uveíte/imunologia , Uveíte/prevenção & controle , Animais , Doenças Autoimunes/patologia , Modelos Animais de Doenças , Humanos , Imunização , Interferon gama/biossíntese , Interleucina-10/biossíntese , Masculino , Molsidomina/farmacologia , Ratos , Ratos Endogâmicos Lew , Retinite/patologia , Proteínas de Ligação ao Retinol/imunologia , Células Th2/efeitos dos fármacos , Células Th2/imunologia , Uveíte/patologia
14.
Int Immunopharmacol ; 4(3): 377-86, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15037215

RESUMO

We investigated the effects of the gallotannin penta-O-galloyl-beta-d-glucose (PGG) on interleukin (IL)-8 gene expression and nuclear factor (NF)-kappaB activation. PGG inhibited IL-8 production and gene expression in human monocytic U937 cells stimulated with phorbol myristate acetate (PMA), as measured by enzyme-linked immunosorbent assay and reverse transcription-polymerase chain reaction analysis, respectively. PGG also inhibited PMA-mediated NF-kappaB activation, as measured by electromobility shift assay. Furthermore, PGG prevented PMA-mediated degradation of the NF-kappaB inhibitory protein I-kappaBalpha, as measured by Western blot analysis. PGG also inhibited both IL-8 production and NF-kappaB activation in the U937 cells stimulated with tumor necrosis factor-alpha. These results suggest that PGG, a major constituent of the root cortex of Paeonia suffruticosa ANDREWS, can inhibit IL-8 gene expression by a mechanism involving its inhibition of NF-kappaB activation, which is dependent on I-kappaBalpha degradation.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Taninos Hidrolisáveis/farmacologia , Interleucina-8/antagonistas & inibidores , NF-kappa B/antagonistas & inibidores , Acetato de Tetradecanoilforbol/farmacologia , Transporte Ativo do Núcleo Celular , Western Blotting , Ensaio de Desvio de Mobilidade Eletroforética , Ensaio de Imunoadsorção Enzimática , Regulação da Expressão Gênica , Humanos , Proteínas I-kappa B/metabolismo , Interleucina-8/biossíntese , Interleucina-8/genética , Transporte Proteico , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fatores de Tempo , Células U937
15.
Int Immunopharmacol ; 1(4): 777-84, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11357890

RESUMO

High amounts of nitric oxide (NO) production following the induction of inducible NO synthase (iNOS) gene expression has been implicated in the pathogenesis of inflammatory diseases. Capsaicin, a vanilloid receptor agonist, is known to have an inhibitory effect on NO production in macrophages. In the present study, we have found that capsazepine (CAPZ), a vanilloid receptor antagonist, also inhibited NO and iNOS protein syntheses induced by lipopolysaccharide in RAW264.7 macrophages via the suppression of iNOS mRNA. The mechanistic studies showed that CAPZ inhibited the expression of iNOS mRNA through the inactivation of nuclear transcription factor-kappa B (NF-kappa B). Thus, capsazepine may be a useful candidate for the development of a drug to treat inflammatory diseases related to iNOS gene overexpression.


Assuntos
Capsaicina/análogos & derivados , Capsaicina/farmacologia , Lipopolissacarídeos/farmacologia , Macrófagos/enzimologia , NF-kappa B/antagonistas & inibidores , Óxido Nítrico Sintase/antagonistas & inibidores , Receptores de Droga/antagonistas & inibidores , Animais , Linhagem Celular , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Camundongos , Óxido Nítrico/biossíntese , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase Tipo II , RNA Mensageiro/análise
16.
Int Immunopharmacol ; 2(8): 1173-81, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12349954

RESUMO

Catalposide, the major iridoid glycoside isolated from the stem bark of Catalpa ovata G. Don (Bignoniaceae), was found to inhibit the productions of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and interleukin-6 (IL-6), and the activation of nuclear factor kappaB (NF-kappaB) in RAW 264.7 macrophages activated with lipopolysaccharide (LPS). Catalposide also inhibited the expressions of TNF-alpha, IL-1beta, and IL-6 genes and the nuclear translocation of p65 subunit of NF-kappaB in LPS-activated RAW 264.7 cells. Flow cytometric analysis revealed that catalposide suppressed the binding of FITC-conjugated LPS to CD14 on the surface of cells, probably resulting in the inhibitory effects on TNF-alpha, IL-1beta, and IL-6 productions and NF-kappaB activation. These findings suggest that catalposide could be an attractive candidate for adjunctive therapy in gram-negative bacterial infections.


Assuntos
Bignoniaceae , Glucosídeos/farmacologia , Interleucina-1/antagonistas & inibidores , Interleucina-6/antagonistas & inibidores , Macrófagos/efeitos dos fármacos , NF-kappa B/antagonistas & inibidores , Animais , Bignoniaceae/química , Linhagem Celular , Glucosídeos/química , Glucosídeos/isolamento & purificação , Glicosídeos/química , Glicosídeos/isolamento & purificação , Glicosídeos/farmacologia , Interleucina-1/biossíntese , Interleucina-6/biossíntese , Lipopolissacarídeos/farmacologia , Macrófagos/metabolismo , Camundongos , NF-kappa B/metabolismo , Casca de Planta , Extratos Vegetais/química , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/farmacologia
17.
Toxicol In Vitro ; 17(1): 49-57, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12537962

RESUMO

Recently we have reported that the trichothecene mycotoxin 4-acetyl-12,13-epoxyl-9-trichothecene-3,15-diol (AETD) from the fruiting bodies of Isaria japonica Yasuda is a potent inducer of apoptosis in human promyelocytic HL-60 cells. The present study aims to characterize the molecular events leading to AETD-induced apoptosis in HL-60 cells. The percentage of apoptotic cells (annexin-V-positive cell population) increased dose- and time-dependently after AETD exposure. Apoptosis of HL-60 cells by AETD was associated with the formation of intracellular reactive oxygen species (ROS), the depletion of intracellular glutathione (GSH) and the activation of caspase-3. Pretreating the cells with the antioxidant N-acetyl-L-cystein (NAC) and the caspase-3 inhibitor Z-DEVD-fmk abrogated AETD-induced apoptosis and caspase-3 activation. NAC blocked intracellular ROS formation and GSH depletion, but Z-DEVD-fmk did not. These results indicate that AETD induces apoptosis in HL-60 cells by causing intracellular ROS formation and GSH depletion followed by the downstream event of caspase-3 activation.


Assuntos
Apoptose/efeitos dos fármacos , Ascomicetos/química , Espécies Reativas de Oxigênio/efeitos adversos , Tricotecenos/farmacologia , Caspase 3 , Caspases/farmacologia , Relação Dose-Resposta a Droga , Glutationa/metabolismo , Células HL-60 , Humanos
18.
J Ethnopharmacol ; 76(1): 59-64, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11378282

RESUMO

The rhizomes of Cyperus rotundus (C. rotundus) have been used in oriental traditional medicines for the treatment of stomach and bowel disorders, and inflammatory diseases. Nitric oxide (NO) and superoxide (O2-) are important mediators in the pathogenesis of inflammatory diseases. This study was undertaken to address whether the metanol (MeOH) extract of rhizomes of C. rotundus could modulate NO and O2- productions by murine macrophage cell line, RAW 264.7 cells. The MeOH extract of rhizomes of C. rotundus showed the inhibition of NO production in a dose-dependent manner by RAW 264.7 cells stimulated with interferon-gamma plus lipopolysaccharide. The inhibition of NO production by the extract was due to the suppression of iNOS protein, as well as iNOS mRNA expression, determined by Western and Northern blotting analyses, respectively. In addition, the MeOH extract suppressed the production of O2- by phorbol ester-stimulated RAW 264.7 cells in dose- and time-dependent manners. Collectively, these results suggest that the MeOH extract of rhizomes of C. rotundus could be developed as anti-inflammatory candidate for the treatment of inflammatory diseases mediated by overproduction of NO and O2-.


Assuntos
Macrófagos/efeitos dos fármacos , Óxido Nítrico/biossíntese , Extratos Vegetais/uso terapêutico , Plantas Medicinais , Superóxidos/metabolismo , Animais , Northern Blotting , Western Blotting , Linhagem Celular , Inflamação/etiologia , Inflamação/prevenção & controle , Coreia (Geográfico) , Macrófagos/metabolismo , Camundongos , Óxido Nítrico/efeitos adversos , Superóxidos/efeitos adversos
19.
J Ethnopharmacol ; 76(1): 119-23, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11378293

RESUMO

In the present study, we examined the effects of the aqueous extract of Rhodiola sachalinensis root (RSE) on the expression of inducible nitric oxide (NO) synthase (iNOS) gene in RAW264.7 macrophages. RSE synergistically increased NO synthesis in interferon-gamma-primed macrophages. Reverse transcriptase polymerase chain reaction and Northern blotting analysis revealed that RSE may provide a second triggering signal for the synergistic induction of iNOS mRNA expression. Thus, iNOS-mediated NO synthesis in response to RSE may be one mechanism whereby this herbal medicine elicits its therapeutic effects.


Assuntos
Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Macrófagos/efeitos dos fármacos , Óxido Nítrico Sintase/efeitos dos fármacos , Extratos Vegetais/farmacologia , Raízes de Plantas , Animais , Células Cultivadas , Indução Enzimática/efeitos dos fármacos , Interferon gama/farmacologia , Macrófagos/enzimologia , Camundongos , Óxido Nítrico Sintase/genética , Extratos Vegetais/isolamento & purificação , RNA Mensageiro/efeitos dos fármacos , Reação em Cadeia da Polimerase Via Transcriptase Reversa
20.
J Ethnopharmacol ; 73(1-2): 323-7, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11025173

RESUMO

The aim of this study was to investigate the effect of butanol fraction of the aqueous extract of Forsythia koreana fruits on the nitric oxide (NO) production and inducible nitric oxide synthesis (iNOS) gene expression in murine macrophage-like RAW 264.7 cells. Butanol fraction alone affected neither NO production nor iNOS gene expression in macrophage-like RAW 264.7 cells. However, the butanol fraction inhibited NO production and iNOS gene expression in RAW 264. 7 cells stimulated with interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS). These findings suggest that inhibition of NO production by this butanol fraction in RAW 264.7 cells stimulated with IFN-gamma plus LPS was due to the suppression of iNOS gene expression.


Assuntos
Butanóis/farmacologia , Macrófagos/efeitos dos fármacos , Óxido Nítrico/biossíntese , Extratos Vegetais/farmacologia , Análise de Variância , Animais , Butanóis/isolamento & purificação , Células Cultivadas , Interferon gama/farmacologia , Macrófagos/metabolismo , Camundongos , Plantas Medicinais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA